TY - JOUR
T1 - Collapsing Focal Segmental Glomerulosclerosis in Siblings With Compound Heterozygous Variants in NUP93 Expand the Spectrum of Kidney Phenotypes Associated With Nucleoporin Gene Mutations
AU - Cason, Rachel K.
AU - Williams, Anna
AU - Chryst-Stangl, Megan
AU - Wu, Guanghong
AU - Huggins, Kinsie
AU - Brathwaite, Kaye E.
AU - Lane, Brandon M.
AU - Greenbaum, Larry A.
AU - D’Agati, Vivette D.
AU - Gbadegesin, Rasheed A.
N1 - Funding Information:
RG was supported by the National Institutes of Health/National Institutes of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) (grants 5R01DK098135 and 5R01DK094987), NIH/NICHD (1R21HD104176-01), Doris Duke Charitable Foundation Clinical Scientist Development (Award 2009033), Borden Scholars award, and Duke Health Scholars award.
Publisher Copyright:
Copyright © 2022 Cason, Williams, Chryst-Stangl, Wu, Huggins, Brathwaite, Lane, Greenbaum, D’Agati and Gbadegesin.
PY - 2022/7/7
Y1 - 2022/7/7
N2 - Background: Focal segmental glomerulosclerosis (FSGS) is a major cause of end stage kidney disease, with the collapsing form having the worst prognosis. Study of families with hereditary FSGS has provided insight into disease mechanisms. Methods: In this report, we describe a sibling pair with NUP93 mutations and collapsing FSGS (cFSGS). For each brother, we performed next generation sequencing and segregation analysis by direct sequencing. To determine if the variants found in the index family are a common cause of cFSGS, we screened 7 patients with cFSGS, gleaned from our cohort of 200 patients with FSGS, for variants in NUP93 as well as for APOL1 high-risk genotypes. Results: We identified segregating compound heterozygous NUP93 variants (1) c.1772G > T p.G591V, 2) c.2084T > C p.L695S) in the two brothers. We did not find any pathogenic variants in the seven patients with cFSGS from our cohort, and as expected five of these seven patients carried the APOL1 high-risk genotype. Conclusion: To the best of our knowledge, this is the first report of cFSGS in patients with NUP93 mutations, based on this report, mutations in NUP93 and other nucleoporin genes should be considered when evaluating a child with familial cFSGS. Determining the mechanisms by which these variants cause cFSGS may provide insight into the pathogenesis of the more common primary and virus-mediated forms of cFSGS.
AB - Background: Focal segmental glomerulosclerosis (FSGS) is a major cause of end stage kidney disease, with the collapsing form having the worst prognosis. Study of families with hereditary FSGS has provided insight into disease mechanisms. Methods: In this report, we describe a sibling pair with NUP93 mutations and collapsing FSGS (cFSGS). For each brother, we performed next generation sequencing and segregation analysis by direct sequencing. To determine if the variants found in the index family are a common cause of cFSGS, we screened 7 patients with cFSGS, gleaned from our cohort of 200 patients with FSGS, for variants in NUP93 as well as for APOL1 high-risk genotypes. Results: We identified segregating compound heterozygous NUP93 variants (1) c.1772G > T p.G591V, 2) c.2084T > C p.L695S) in the two brothers. We did not find any pathogenic variants in the seven patients with cFSGS from our cohort, and as expected five of these seven patients carried the APOL1 high-risk genotype. Conclusion: To the best of our knowledge, this is the first report of cFSGS in patients with NUP93 mutations, based on this report, mutations in NUP93 and other nucleoporin genes should be considered when evaluating a child with familial cFSGS. Determining the mechanisms by which these variants cause cFSGS may provide insight into the pathogenesis of the more common primary and virus-mediated forms of cFSGS.
KW - APOL1
KW - collapsing FSGS
KW - focal segmental glomerulosclerosis
KW - nephrotic syndrome
KW - nucleoporin genes
UR - http://www.scopus.com/inward/record.url?scp=85134482533&partnerID=8YFLogxK
U2 - 10.3389/fped.2022.915174
DO - 10.3389/fped.2022.915174
M3 - Article
C2 - 35874595
AN - SCOPUS:85134482533
SN - 2296-2360
VL - 10
JO - Frontiers in Pediatrics
JF - Frontiers in Pediatrics
M1 - 915174
ER -